UW–Madison inventors aim to replace old-style breast-surgery marker
Three University of Wisconsin–Madison innovators have invented a better way for surgeons to locate tumors during lumpectomies for breast cancer.
UW Carbone Cancer Center physicians: All cancer patients should be screened for Hepatitis C
All cancer patients should be screened for exposure to the Hepatitis C virus because cancer treatment can make an active viral infection worse, according to a statement published this month in the Journal of Oncology Practice.
Biostatistics and medical informatics tapped for $11.8 million national coordinating center
A University of Wisconsin-Madison professor and his team have been chosen to lead the nation’s coordinating center for the National Cancer Institute (NCI) Cancer Prevention Clinical Trials Network (CP-CTNet).
Cancer research conference focuses on targeted radionuclide therapy
University of Wisconsin-Madison is hosting a national conference on targeted radionuclide therapy (TRT), a promising new technology that combines cytotoxic radioisotopes with molecularly targeted agents to produce an anti-cancer therapy capable of treating local or systemic disease.
Simultaneous infection by two viruses the key to studying rare lymphoma
New research has found that a rare blood cancer can be simulated in the lab only by simultaneously infecting white blood cells with two viruses typically found in the tumors.
Researchers probe cell division defects to gain insight into cancer
From bugs to plants to animals, for all living things to grow they must create more cells.
Study: risk-based breast cancer screenings lack predictive value
Starting breast-cancer screenings based on personal risk factors instead of age in women 40-49 years of age may significantly delay the detection of some early-stage breast cancers while also decreasing the number of false-positive mammograms and biopsies that reveal growths that are benign, according to new research from the University of Wisconsin School of Medicine and Public Health.
UW study provides potential treatment strategy for aggressive lymphoma
A research team at the University of Wisconsin Carbone Cancer Center has found a new tumor-causing mechanism that contributes to the development of the most common form of non-Hodgkin lymphoma.
13 Carbone Cancer Center researchers earn prestigious campus and national awards
Thirteen University of Wisconsin Carbone Cancer Center researchers have earned prestigious campus honors. The awards were announced in early May.
Carbone Cancer Center members take new leadership roles
Four members of the University of Wisconsin Carbone Cancer Center have been named to new leadership roles.
Personalized in vitro model enables drug screening for kidney cancer
One way to treat the most common type of kidney cancer is to use antiangiogenic drugs to cut off the blood supply to the tumors, but patients respond differently to the drugs, and choosing the wrong one can make the cancer grow faster.
The Ride funds $365,000 in research at Carbone Cancer Center
On a beautiful September Sunday, hundreds of bicyclists pedaled the roads of eastern Dane County on The Ride to raise money for cancer research.